Franklin Biotechnology Discv C Acc $

Performance History31/12/2016
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv C Acc $
Fund32.6101.547.939.8-28.0
+/-Cat-0.56.53.9-3.81.0
+/-Idx-18.8-5.63.5-4.4-5.5
 
Key Stats
NAV
23/01/2017
 USD 33.04
Day Change -1.52%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0260873095
Fund Size (Mil)
31/12/2016
 USD 2182.40
Share Class Size (Mil)
31/12/2016
 USD 15.43
Max Initial Charge -
Ongoing Charge
08/06/2016
  2.39%
Investment Objective: Franklin Biotechnology Discv C Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns23/01/2017
YTD1.18
3 Years Annualised7.83
5 Years Annualised30.43
10 Years Annualised18.58
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
01/09/2006
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv C Acc $31/10/2016
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks93.160.0093.16
Bonds0.000.000.00
Cash5.150.005.15
Other1.690.001.69
Top 5 Regions%
United States96.68
United Kingdom1.63
Middle East0.69
Eurozone0.57
Canada0.22
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.61
Biogen IncHealthcareHealthcare7.88
Tesaro IncHealthcareHealthcare7.33
Gilead Sciences IncHealthcareHealthcare7.28
Incyte CorpHealthcareHealthcare4.66
Franklin Biotechnology Discv C Acc $